While we offer compounded medications tailored to individual needs, we also have commercially available drugs for patients when appropriate
The paper Association between eating behavior patterns and the therapeutic efficacy of GLP-1 receptor agonists in individuals with type 2 diabetes: a multicenter prospective observational study was authored by Yuya Koide, Takehiro Kato, Makoto Hayashi, Hisashi Daido, Takako Maruyama, Takuma Ishihara, Kayoko Nishimura, Shin Tsunekawa, and Daisuke Yabe on behalf of G-DIET Investigators
Until these results are available, GLP-1 receptor agonists with established cardiovascular benefits (liraglutide, semaglutide, dulaglutide) are preferred by ADA guidelines for patients with established atherosclerotic cardiovascular disease
In concordance with the uptake data quantified by fluorescent spectroscopy shown on Fig
It makes skin supple and protects dry skin
This finding is encouraging, as it suggests 5-Amino-1MQ works by altering metabolic function rather than suppressing hunger